(Stroke. 1999;30:1598-1603.)
© 1999 American Heart Association, Inc.
Original Contributions |
From the Departments of Emergency Medicine (W.S., F.S., W.B., M.H., M.F., A.N.L.), Dermatology (H.K.), and Laboratory Diagnostics (S.S.), University of Vienna Medical School (Austria).
Correspondence to Fritz Sterz, MD, AKHNotfallaufnahme, Universität Wien, Währinger Gürtel 18-20/6/D, 1090 Wien, Austria. E-mail fritz.sterz{at}akh-wien.ac.at
Background and PurposeThe prediction of neurological outcome in comatose cardiac arrest survivors has enormous ethical and socioeconomic implications. The purpose of the present study was to investigate the prognostic relevance of the time course of serum neuron-specific enolase (NSE) as a biochemical marker of hypoxic brain damage.
MethodsSerial analysis of serum NSE levels was performed in 56 patients resuscitated from witnessed, nontraumatic, normothermic, in- or out-of-hospital cardiac arrest. The neurological outcome was evaluated with the use of the cerebral performance category (CPC) within 6 months after restoration of spontaneous circulation (ROSC). The Mann-Whitney U test was used to compare patients with good (CPC 1 to 2) and bad (CPC 3 to 4) neurological outcome. The diagnostic performance at different time points after ROSC was described in terms of areas under receiver operating characteristic curves according to standard methods.
ResultsPatients with a bad neurological outcome (CPC 3 to 4) had significantly higher NSE levels than those with a good neurological outcome at 12 (P=0.004), 24 (P=0.04), 48 (P<0.001), and 72 hours (P<0.001) after ROSC. The maximum NSE level measured within 72 hours after ROSC was also significantly higher in patients with a bad neurological outcome (P<0.001). The NSE value at 72 hours after ROSC was the best predictor of neurological outcome (area under the curve=0.92±0.04). In addition, we also found a significant difference in the time course of NSE concentrations during the first 3 days after ROSC.
ConclusionsSerum NSE levels are valuable adjunctive parameters for assessing neurological outcome after cardiac arrest.
Key Words: cardiopulmonary resuscitation heart arrest neuron-specific enolase outcome
This article has been cited by other articles:
![]() |
G. B. Young Neurologic Prognosis after Cardiac Arrest N. Engl. J. Med., August 6, 2009; 361(6): 605 - 611. [Full Text] [PDF] |
||||
![]() |
J. Reisinger, K. Hollinger, W. Lang, C. Steiner, T. Winter, E. Zeindlhofer, M. Mori, A. Schiller, A. Lindorfer, K. Wiesinger, et al. Prediction of neurological outcome after cardiopulmonary resuscitation by serial determination of serum neuron-specific enolase Eur. Heart J., January 1, 2007; 28(1): 52 - 58. [Abstract] [Full Text] [PDF] |
||||
![]() |
Part 4: Advanced Life Support Circulation, November 29, 2005; 112(22_suppl): III-25 - III-54. [Full Text] [PDF] |
||||
![]() |
D. M. Bailey, G.-R. Kleger, M. Holzgraefe, P. E. Ballmer, and P. Bartsch Pathophysiological significance of peroxidative stress, neuronal damage, and membrane permeability in acute mountain sickness J Appl Physiol, April 1, 2004; 96(4): 1459 - 1463. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tiainen, R. O. Roine, V. Pettila, and O. Takkunen Serum Neuron-Specific Enolase and S-100B Protein in Cardiac Arrest Patients Treated With Hypothermia Stroke, December 1, 2003; 34(12): 2881 - 2886. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schiefermeier, H. Kollegger, C. Madl, C. Schwarz, M. Holzer, J. Kofler, and F. Sterz Apolipoprotein E Polymorphism : Survival and Neurological Outcome After Cardiopulmonary Resuscitation Stroke, September 1, 2000; 31(9): 2068 - 2073. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Herrmann, A. D. Ebert, I. Galazky, M. T. Wunderlich, W. S. Kunz, and C. Huth Neurobehavioral Outcome Prediction After Cardiac Surgery : Role of Neurobiochemical Markers of Damage to Neuronal and Glial Brain Tissue Stroke, March 1, 2000; 31(3): 645 - 650. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |